Innovation 2.94 3.03 24.11 28.39 (21.17) (87.80%) 3. Companion Animal Healthcare 43.06 44.33 25.70 30.26 17.35 67.51% 4. Livestock 3.36 3.45 3.25 3.82 0.11 3.36% Total Sales Revenue 97.13 100.00 84.93 100.00
-manufacturing business. - Cost of goods sold in business agriculture and dairy farm increased Baht 5.62 million, to be 60% because animal feed price increased. (3) Commission income amount Baht 4.64 million
goods sold in business agriculture and dairy farm increased Baht 2.57 million, to be 6% because animal feed price increased form the year 2016. (3) Commission income amount Baht 9.84 million, increased
increased in revenues from sales of medicated pet shampoo, pet foods products, livestock animal products, and revenues from sales of wellness & anti-aging products and aesthetic innovations products. 2. Cost
growth was driven primarily by an increase in revenues from sales of pet skincare shampoo products, pet food products and livestock animal products, and revenues from sales of wellness & anti-ageing
เซอร์วิส จำกัด (มหาชน) AIT: ADVANCED INFORMATION TECHNOLOGY PUBLIC CO.,LTD. AJA: AJ ADVANCE TECHNOLOGY PUBLIC COMPANY LIMITED ASAP: SYNERGETIC AUTO PERFORMANCE PUBLIC COMPANY LIMITED BIS: Bioscience Animal
COMPANY LIMITED AIT: ADVANCED INFORMATION TECHNOLOGY PUBLIC CO.,LTD. AJA: AJ ADVANCE TECHNOLOGY PUBLIC COMPANY LIMITED ASAP: SYNERGETIC AUTO PERFORMANCE PUBLIC COMPANY LIMITED BIS: Bioscience Animal Health
FinancialStatement 56-1 56-2 Ranking BIS Bioscience Animal Health Public Company Limited Filing FinancialStatement 56-1 56-2 Ranking BCT BIRLA CARBON (THAILAND) PUBLIC COMPANY LIMITED Filing FinancialStatement 56-1 56
by of integrated input/agricultural management plan - Animal feed choices minimising nitrogen excretion and/or methane production Standards for sustainable plant based agriculture (e.g. Ecocert, RSPO
controversial activities screened under our methodology, namely: Animal Welfare. CHANEL appears to not be involved in any of the 16 other controversial activities screened under our methodology (detailed in p.4